Literature DB >> 16053906

CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter).

E Schollen1, S Grünewald, L Keldermans, B Albrecht, C Körner, G Matthijs.   

Abstract

We report on a patient with a congenital disorder of glycosylation type Id (CDG-Id) caused by a homozygous mutation in the ALG3 gene, which results from a de novo mutation in combination with a segmental maternal uniparental isodisomy (UPD). The patient presented with severe psychomotor delay, primary microcephaly, and opticus atrophy, compatible with a severe form of CDG. Isoelectric focusing of transferrin showed a type I pattern and lipid-linked oligosaccharide analysis showed an accumulation of dol-PP-GlcNAc2Man5 in patient's fibroblasts suggesting a defect in the ALG3 gene. A homozygous ALG3 missense mutation p.R266C (c.796C > T) was identified. Further evaluation revealed that neither the mother nor the father were carrier of the p.R266C mutation. Marker analysis revealed a segmental maternal isodisomy for the chromosomal region 3q21.3-3qter. UPD for this region has not been described before. More important, the combination of UPD with a de novo mutation is an exceptional coincidence and an extraordinary observation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16053906     DOI: 10.1016/j.ejmg.2005.01.002

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  13 in total

1.  ALG3-CDG: lethal phenotype and novel variants in Chinese siblings.

Authors:  Yue Bian; Chong Qiao; ShuGuang Zheng; Hao Qiu; Huan Li; ZhiTao Zhang; ShaoWei Yin; HongKun Jiang; Jesse Li-Ling; CaiXia Liu; Yuan Lyu
Journal:  J Hum Genet       Date:  2020-07-12       Impact factor: 3.172

2.  A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism.

Authors:  Eva Morava; Ron A Wevers; Vincent Cantagrel; Lies H Hoefsloot; Lihadh Al-Gazali; Jeroen Schoots; Arno van Rooij; Karin Huijben; Connie M A van Ravenswaaij-Arts; Marjolein C J Jongmans; Jolanta Sykut-Cegielska; Georg F Hoffmann; Peter Bluemel; Maciej Adamowicz; Jeroen van Reeuwijk; Bobby G Ng; Jorieke E H Bergman; Hans van Bokhoven; Christian Körner; Dusica Babovic-Vuksanovic; Michel A Willemsen; Joseph G Gleeson; Ludwig Lehle; Arjan P M de Brouwer; Dirk J Lefeber
Journal:  Brain       Date:  2010-09-17       Impact factor: 13.501

Review 3.  Generation and degradation of free asparagine-linked glycans.

Authors:  Yoichiro Harada; Hiroto Hirayama; Tadashi Suzuki
Journal:  Cell Mol Life Sci       Date:  2015-03-14       Impact factor: 9.261

4.  Identification of the gene encoding the alpha1,3-mannosyltransferase (ALG3) in Arabidopsis and characterization of downstream n-glycan processing.

Authors:  Maurice Henquet; Ludwig Lehle; Mariëlle Schreuder; Gerard Rouwendal; Jos Molthoff; Johannes Helsper; Sander van der Krol; Dirk Bosch
Journal:  Plant Cell       Date:  2008-06-20       Impact factor: 11.277

5.  Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.

Authors:  A Rimella-Le-Huu; H Henry; I Kern; S Hanquinet; E Roulet-Perez; C J Newman; A Superti-Furga; L Bonafé; D Ballhausen
Journal:  J Inherit Metab Dis       Date:  2008-08-09       Impact factor: 4.982

Review 6.  The congenital disorders of glycosylation: a multifaceted group of syndromes.

Authors:  Erik A Eklund; Hudson H Freeze
Journal:  NeuroRx       Date:  2006-04

7.  Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.

Authors:  C Paketci; P Edem; S Hiz; E Sonmezler; D Soydemir; G Sarikaya Uzan; Y Oktay; E O'Heir; S Beltran; S Laurie; A Töpf; H Lochmuller; R Horvath; U Yis
Journal:  Brain Dev       Date:  2020-05-07       Impact factor: 1.961

Review 8.  ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.

Authors:  Martina Farolfi; Anna Cechova; Nina Ondruskova; Jana Zidkova; Bohdan Kousal; Hana Hansikova; Tomas Honzik; Petra Liskova
Journal:  BMC Ophthalmol       Date:  2021-06-05       Impact factor: 2.209

9.  Clinical significance and mechanisms associated with segmental UPD.

Authors:  Peter R Papenhausen; Carla A Kelly; Samuel Harris; Samantha Caldwell; Stuart Schwartz; Andrea Penton
Journal:  Mol Cytogenet       Date:  2021-07-20       Impact factor: 2.009

10.  Congenital disorder of glycosylation type Ix: review of clinical spectrum and diagnostic steps.

Authors:  E Morava; H Wosik; J Kárteszi; M Guillard; M Adamowicz; J Sykut-Cegielska; K Hadzsiev; R A Wevers; D J Lefeber
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.